Clinical trialPhase 2

PURIFY-TIMI 81 (YN001)

NCT07521007

Phase 2b, N≈456, randomized double-blind placebo-controlled; primary endpoint relative change coronary noncalcified plaque volume.

1 news item

News about this trial

Scales

Identifiers

NCT
NCT07521007

Original sources

Details

Phase
Phase 2
Status
Recruiting

A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.